The Effect of Programmed Intermittent Epidural Bolus Versus Continuous Epidural Infusion on Postoperative Analgesia in Pediatric Patients
Launched by YONSEI UNIVERSITY · Jul 2, 2019
Trial Information
Current as of May 22, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Pediatric patients with between 4 and 13 years
- • 2. Patients scheduled for correctional osteotomy of the lower extremity
- • 3. Pediatric patients whose weight of 40kg of less
- Exclusion Criteria:
- • 1. Contraindications to epidural analgesia (local infection, blood clotting disorder, anatomical abnormality, sepsis, etc.)
- • 2. Patients with symptoms/signs of elevated intracranial pressure with or without a history of elevated intracranial pressure
- • 3. If all of the parents of the subject are foreigners or illiterate (if the parents of the subject can not read the agreement)
About Yonsei University
Yonsei University, a prestigious institution located in South Korea, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Yonsei University leverages its extensive expertise and innovative approaches in various fields of medicine to conduct rigorous clinical trials aimed at improving patient outcomes and advancing healthcare solutions. The university's robust infrastructure, multidisciplinary collaboration, and adherence to ethical standards ensure the integrity and reliability of its research initiatives, making it a key player in the global clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials